Skip to main content
Erschienen in: Acta Diabetologica 4/2009

01.12.2009 | Original Article

Alterations in l-arginine and inflammatory markers in type 2 diabetic patients with and without microalbuminuria

verfasst von: Necla Barış, Mehmet Erdoğan, Ebru Sezer, Füsun Saygılı, A. Mert Özgönül, Nevbahar Turgan, Biltan Ersöz

Erschienen in: Acta Diabetologica | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Low-grade inflammation is closely involved in the pathogenesis of type 2 diabetes and associated micro- and macrovascular complications. The nitric oxide (NO) precursor l-arginine, is relevant to diverse pathological conditions including type 2 diabetes and its complications. High sensitive-CRP (hs-CRP), neopterin and arginine levels were measured in 46 normoalbuminuric, 45 microalbuminuric type 2 diabetics and in 32 healthy controls in order to assess the relationship between markers of inflammation and l-arginine. Hs-CRP concentrations were higher in microalbuminuric diabetic patients compared to normoalbuminuric patients and controls. Diabetics had higher serum and urine neopterin levels than controls. Urine neopterin and l-arginine levels differed significantly among diabetic patients with and without microalbuminuria. There were significant positive correlations between hs-CRP and BMI in healthy controls and diabetics with and without microalbuminuria. In microalbuminuric diabetics, hs-CRP correlated with microalbuminuria (MAU). Significant predictors for the development of microalbuminuria were higher postprandial glucose levels, lower creatinine clearance and lower serum l-arginine levels. Assessment of early markers of inflammation and endothelial function, such as neopterin and NO precursor l-arginine, may help to predict incipient nephropathy more accurately in type 2 diabetic patients.
Literatur
1.
Zurück zum Zitat Trachtman H, Futterweit S, Pine E, Mann J, Valderrama E (2002) Chronic diabetic nephropathy: role of inducible nitric oxide synthase. Pediatr Nephrol 17:20–29CrossRefPubMed Trachtman H, Futterweit S, Pine E, Mann J, Valderrama E (2002) Chronic diabetic nephropathy: role of inducible nitric oxide synthase. Pediatr Nephrol 17:20–29CrossRefPubMed
2.
Zurück zum Zitat Fraser DJ, Phillips AO (2007) Diabetic nephropathy. Medicine 35(9):503–506CrossRef Fraser DJ, Phillips AO (2007) Diabetic nephropathy. Medicine 35(9):503–506CrossRef
3.
Zurück zum Zitat Friedman AN, Hunsicker LG, Selhub J, Bostom AG (2004) Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy. Atherosclerosis 172:121–125CrossRefPubMed Friedman AN, Hunsicker LG, Selhub J, Bostom AG (2004) Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy. Atherosclerosis 172:121–125CrossRefPubMed
4.
Zurück zum Zitat Pecoits-Filho R, Sylvestre LC, Stenvinkel P (2005) Chronic kidney disease and inflammation in pediatric patients: from bench to playground. Pediatr Nephrol 20:714–720CrossRefPubMed Pecoits-Filho R, Sylvestre LC, Stenvinkel P (2005) Chronic kidney disease and inflammation in pediatric patients: from bench to playground. Pediatr Nephrol 20:714–720CrossRefPubMed
5.
Zurück zum Zitat Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111:1805–1812PubMed Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111:1805–1812PubMed
6.
Zurück zum Zitat Yeh ETH (2004) CRP as a mediator of disease. Circulation 109(Suppl II):11–14 Yeh ETH (2004) CRP as a mediator of disease. Circulation 109(Suppl II):11–14
7.
Zurück zum Zitat Lhee HY, Kim H, Joo KJ, Jung SS, Lee KB (2006) The clinical significance of serum and urinary neopterin levels in several renal diseases. J Korean Med Sci 21:678–682PubMed Lhee HY, Kim H, Joo KJ, Jung SS, Lee KB (2006) The clinical significance of serum and urinary neopterin levels in several renal diseases. J Korean Med Sci 21:678–682PubMed
8.
Zurück zum Zitat Hoffmann G, Wirleitner B, Fuchs D (2003) Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflam Res 52:313–321CrossRef Hoffmann G, Wirleitner B, Fuchs D (2003) Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflam Res 52:313–321CrossRef
9.
Zurück zum Zitat Siasos G, Tousoulis D, Antoniades C, Stefanadi E, Stefanadis C (2007) l-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis? Int J Cardiol 116(3):300–308CrossRefPubMed Siasos G, Tousoulis D, Antoniades C, Stefanadi E, Stefanadis C (2007) l-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis? Int J Cardiol 116(3):300–308CrossRefPubMed
10.
Zurück zum Zitat Mendez JD, Balderas FL (2006) Inhibition by l-arginine and spermidine of hemoglobin glycation and lipid peroxidation in rats with induced diabetes. Biomed Pharmacother 60(1):26–31CrossRefPubMed Mendez JD, Balderas FL (2006) Inhibition by l-arginine and spermidine of hemoglobin glycation and lipid peroxidation in rats with induced diabetes. Biomed Pharmacother 60(1):26–31CrossRefPubMed
11.
Zurück zum Zitat Kabat A, Dhein S (2006) l-arginine supplementation prevents the development of endothelial dysfunction in hyperglycaemia. Pharmacology 78:185–191CrossRef Kabat A, Dhein S (2006) l-arginine supplementation prevents the development of endothelial dysfunction in hyperglycaemia. Pharmacology 78:185–191CrossRef
12.
Zurück zum Zitat Sarafidis PA, Ruilope LM (2006) Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol 26(3):232–244CrossRefPubMed Sarafidis PA, Ruilope LM (2006) Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol 26(3):232–244CrossRefPubMed
13.
Zurück zum Zitat Chin-Dusting JPF, Willems L, Kaye DM (2007) l-Arginine transporters in cardiovascular disease: a novel therapeutic target. Pharmacol Ther 116:428–436CrossRefPubMed Chin-Dusting JPF, Willems L, Kaye DM (2007) l-Arginine transporters in cardiovascular disease: a novel therapeutic target. Pharmacol Ther 116:428–436CrossRefPubMed
14.
Zurück zum Zitat American Diabetes Association (2008) Position statement. Standards of Medical Care in Diabetes. Diabetes Care 31(suppl 1):S12–S54CrossRef American Diabetes Association (2008) Position statement. Standards of Medical Care in Diabetes. Diabetes Care 31(suppl 1):S12–S54CrossRef
15.
Zurück zum Zitat Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289:2560–2572CrossRefPubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289:2560–2572CrossRefPubMed
16.
Zurück zum Zitat Meijer JW, Smit AJ, Sonderen EV, Groothoff JW, Eisma WH, Links TP (2002) Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score. Diabet Med 19(11):962–965CrossRefPubMed Meijer JW, Smit AJ, Sonderen EV, Groothoff JW, Eisma WH, Links TP (2002) Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score. Diabet Med 19(11):962–965CrossRefPubMed
17.
Zurück zum Zitat Turgan N, Habif S, Parıldar Z, Ozmen D, Mutaf I, Erdener D, Bayindir O (2001) Association between homocysteine and neopterin in healthy subjects measured by a simple HPLC-fluorometric method. Clin Biochem 33:271–275CrossRef Turgan N, Habif S, Parıldar Z, Ozmen D, Mutaf I, Erdener D, Bayindir O (2001) Association between homocysteine and neopterin in healthy subjects measured by a simple HPLC-fluorometric method. Clin Biochem 33:271–275CrossRef
19.
Zurück zum Zitat Gomes MB, Nogueira VG (2004) Acute-phase proteins and microalbuminuria among patients with type 2 diabetes. Diabetes Res Clin Pract 66(1):31–39CrossRefPubMed Gomes MB, Nogueira VG (2004) Acute-phase proteins and microalbuminuria among patients with type 2 diabetes. Diabetes Res Clin Pract 66(1):31–39CrossRefPubMed
20.
Zurück zum Zitat Aronson D, Bartha P, Zinder O, Kerner A, Shitman E, Markiewicz W, Brook GJ, Levy Y (2004) Association between fasting glucose and CRP in middle-aged subjects. Diabet Med 21:39–44CrossRefPubMed Aronson D, Bartha P, Zinder O, Kerner A, Shitman E, Markiewicz W, Brook GJ, Levy Y (2004) Association between fasting glucose and CRP in middle-aged subjects. Diabet Med 21:39–44CrossRefPubMed
21.
Zurück zum Zitat Abdella NA, Mojiminiyit OA, Moussa MA, Zaki M, Al Mohammedi H, Al Ozairi ES, Al Jebely S (2005) Plasma leptin concentrations in patients with type 2 diabetes: relationship to cardiovascular risk factors and insulin resistance. Diabet Med 22:278–285CrossRefPubMed Abdella NA, Mojiminiyit OA, Moussa MA, Zaki M, Al Mohammedi H, Al Ozairi ES, Al Jebely S (2005) Plasma leptin concentrations in patients with type 2 diabetes: relationship to cardiovascular risk factors and insulin resistance. Diabet Med 22:278–285CrossRefPubMed
22.
Zurück zum Zitat Tsioufis C, Dimitriadis K, Taxiarchou E, Vasiliadou C, Chartzoulakis G, Tousoulis D, Manolis A, Stefanadis C, Kallikazaros I (2006) Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects. Am J Hypertens 19(5):462–466CrossRefPubMed Tsioufis C, Dimitriadis K, Taxiarchou E, Vasiliadou C, Chartzoulakis G, Tousoulis D, Manolis A, Stefanadis C, Kallikazaros I (2006) Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects. Am J Hypertens 19(5):462–466CrossRefPubMed
23.
Zurück zum Zitat Stehouwer CD, Smulders YM (2006) Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol 17(8):2106–2111CrossRefPubMed Stehouwer CD, Smulders YM (2006) Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol 17(8):2106–2111CrossRefPubMed
24.
Zurück zum Zitat Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, Da Ros R, Motz E (2002) Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation effects of short- and long-term simvastatin treatment. Circulation 106:1211–1218CrossRefPubMed Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, Da Ros R, Motz E (2002) Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation effects of short- and long-term simvastatin treatment. Circulation 106:1211–1218CrossRefPubMed
25.
Zurück zum Zitat Negrean M, Stirban A, Stratmann B, Gawlowski T, Horstmann T, Götting C, Kleesiek K, Michaela Mueller-Roesel M, Koschinsky T, Uribarri J, Vlassara H, Tschoepe D (2007) Effects of low- and high-advanced glycation end product meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr 85(5):1236–1243PubMed Negrean M, Stirban A, Stratmann B, Gawlowski T, Horstmann T, Götting C, Kleesiek K, Michaela Mueller-Roesel M, Koschinsky T, Uribarri J, Vlassara H, Tschoepe D (2007) Effects of low- and high-advanced glycation end product meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr 85(5):1236–1243PubMed
26.
Zurück zum Zitat Gupta S, Fredericks S, Schwartzman RA, Kaski JC (1997) Serum neopterin in acute coronary syndromes. Lancet 349:1252–1253CrossRefPubMed Gupta S, Fredericks S, Schwartzman RA, Kaski JC (1997) Serum neopterin in acute coronary syndromes. Lancet 349:1252–1253CrossRefPubMed
27.
Zurück zum Zitat Anwaar I, Gottsater A, Eriksson KF, Jacobsson L, Lindgärde F, Mattiasson I (2000) Increased plasma enothelin-1 and intraplatelet cGMP in men with disturbed glucose metabolism. Diabetes Res Clin Pract 50:127–136CrossRefPubMed Anwaar I, Gottsater A, Eriksson KF, Jacobsson L, Lindgärde F, Mattiasson I (2000) Increased plasma enothelin-1 and intraplatelet cGMP in men with disturbed glucose metabolism. Diabetes Res Clin Pract 50:127–136CrossRefPubMed
28.
Zurück zum Zitat Weiss MF, Rodby RA, Justice AC, Hricik DE (1998) The Collaborative Study Group. Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Kidney Int 54:193–202PubMed Weiss MF, Rodby RA, Justice AC, Hricik DE (1998) The Collaborative Study Group. Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Kidney Int 54:193–202PubMed
29.
Zurück zum Zitat Klahr S, Morrissey J (2004) l-arginine as a therapeutic tool in kidney disease. Semin Nephrol 24(4):389–394CrossRefPubMed Klahr S, Morrissey J (2004) l-arginine as a therapeutic tool in kidney disease. Semin Nephrol 24(4):389–394CrossRefPubMed
Metadaten
Titel
Alterations in l-arginine and inflammatory markers in type 2 diabetic patients with and without microalbuminuria
verfasst von
Necla Barış
Mehmet Erdoğan
Ebru Sezer
Füsun Saygılı
A. Mert Özgönül
Nevbahar Turgan
Biltan Ersöz
Publikationsdatum
01.12.2009
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 4/2009
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-008-0089-9

Weitere Artikel der Ausgabe 4/2009

Acta Diabetologica 4/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.